Clinical Trial Update: Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase II results update for a capecitabine and cisplatin regimen in metastatic triple-negative breast cancer. The results were posted in 2015 and the study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2015-02-23